TABLE 2.
ASTROCYTOMA INCIDENCE AND AVERAGE AGE AT DEATH WITH ASTROCYTOMA
Pat Crosses | N | % Astro | Pa | Age (mo) | Pb | P Sex*GTPc |
---|---|---|---|---|---|---|
B6-NPcispat, all | 90 | 51% | 0.0003 | 5.7 ± 1.9 | <0.0001 | 0.93 |
CSS19-NPcispat, all | 52 | 21% | 7.2 ± 1.8 | |||
B6-NPcispat, females | 45 | 56% | 0.0037 | 5.6 ± 1.8 | 0.0002 | |
CSS19-NPcispat, females | 34 | 31% | 6.9 ± 2.0 | |||
B6-NPcispat, males | 45 | 47% | 0.021 | 5.8 ± 1.9 | 0.016 | |
CSS19-NPcispat, males | 18 | 17% | 7.8 ± 1.3 | |||
Mat Crosses | ||||||
B6-NPcismat, all | 86 | 62% | 0.0019 | 7.3 ± 2.0 | 0.0009 | 0.0040 |
CSS19-NPcismat, all | 18 | 22% | 8.9 ± 0.8 | |||
B6-NPcismat, females | 38 | 50% | 0.57 | 7.5 ± 1.9 | 0.21 | |
CSS19-NPcismat, females | 10 | 40% | 8.9 ± 0.8 | |||
B6-NPcismat, males | 48 | 71% | <0.0001 | 7.2 ± 2.1 | 0.0018 | |
CSS19-NPcismat, males | 8 | 0% | NA |
Likelihood Ratio Chi square test for significance
Log rank test for significance
Logistic regression test for significance of interaction between sex and genotype